Aurinia Pharmaceuticals Inc (AUPH)
5.77
+0.46
(+8.66%)
USD |
NASDAQ |
May 16, 16:00
5.77
0.00 (0.00%)
After-Hours: 20:00
Aurinia Pharmaceuticals Total Return Level: 5.77 for May 16, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 16, 2024 | 5.77 |
May 15, 2024 | 5.31 |
May 14, 2024 | 5.20 |
May 13, 2024 | 5.02 |
May 10, 2024 | 5.02 |
May 09, 2024 | 5.17 |
May 08, 2024 | 5.15 |
May 07, 2024 | 5.12 |
May 06, 2024 | 5.16 |
May 03, 2024 | 5.10 |
May 02, 2024 | 5.17 |
May 01, 2024 | 5.20 |
April 30, 2024 | 5.09 |
April 29, 2024 | 5.01 |
April 26, 2024 | 4.91 |
April 25, 2024 | 4.87 |
April 24, 2024 | 5.03 |
April 23, 2024 | 5.09 |
April 22, 2024 | 5.05 |
April 19, 2024 | 4.99 |
April 18, 2024 | 4.81 |
April 17, 2024 | 4.91 |
April 16, 2024 | 5.00 |
April 15, 2024 | 5.04 |
April 12, 2024 | 5.10 |
Date | Value |
---|---|
April 11, 2024 | 5.08 |
April 10, 2024 | 4.99 |
April 09, 2024 | 5.11 |
April 08, 2024 | 4.98 |
April 05, 2024 | 5.05 |
April 04, 2024 | 5.09 |
April 03, 2024 | 5.18 |
April 02, 2024 | 5.08 |
April 01, 2024 | 5.40 |
March 28, 2024 | 5.01 |
March 27, 2024 | 5.00 |
March 26, 2024 | 4.93 |
March 25, 2024 | 4.99 |
March 22, 2024 | 4.97 |
March 21, 2024 | 5.01 |
March 20, 2024 | 5.14 |
March 19, 2024 | 5.18 |
March 18, 2024 | 5.09 |
March 15, 2024 | 5.17 |
March 14, 2024 | 5.09 |
March 13, 2024 | 5.25 |
March 12, 2024 | 5.20 |
March 11, 2024 | 5.37 |
March 08, 2024 | 5.43 |
March 07, 2024 | 5.45 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
3.88
Minimum
Oct 14 2019
33.08
Maximum
Oct 29 2021
11.78
Average
11.21
Median
May 18 2022
Total Return Level Benchmarks
Lexaria Bioscience Corp | 3.14 |
Acasti Pharma Inc | 2.760 |
Edesa Biotech Inc | 4.52 |
Xenon Pharmaceuticals Inc | 40.34 |
ESSA Pharma Inc | 6.25 |